The Big Loser After Gilead's Latest Approval May Not Be Who You Think (Hint: It's not AbbVie, Inc.)
Image source: stockmonkeys.com via Flickr. Guess what? The FDA approved Gilead Sciences (NASDAQ:GILD) newest hepatitis C drug, Epclusa, earlier this week. Not surprised? You're not alone. After delivering 98% cure rates and arguably best-in-class safety in trials, just about everyone believed the FDA would give Epclusa a green light. Yet Gilead Sciences shares jumped 4% higher on news of Epclusa's approval, leaving many to wonder why a green light hadn't been priced into shares ahead of the de..>> view originalUS Businesses Guilty of Providing Unapproved Stem Cell Treatment According to Reports
US Businesses Guilty of Providing Unapproved Stem Cell Treatment According to Reports Those Businesses are Operating Without Permission From the FDA By Staff Writer | Jul 03, 2016 10:15 AM EDT (Photo : Getty Images) In a sensational turn of events that could have far reaching ramifications for the large and thriving stem sell treatment industry in the United States, a study by the Universities of California and Minnesota has revealed that there is a substantial number of businesses in the U..>> view originalRed Cross to host several blood drives in Prescott July 5-8
The American Red Cross urges eligible donors to give blood in the weeks surrounding Independence Day to help ensure a sufficient blood supply for patients now and throughout the summer. Blood donations often decline in the summer months, especially around summer holidays when donors are less available to give. The need for blood doesn’t decrease though – every two seconds, someone in the U.S. requires blood or platelets. In fact, a recent survey of Red Cross blood and platelet donors showed tha..>> view originalOSHA injury rules changing
At a glance The following are workers’ rights, as outlined by OSHA. Workers have the right to: • Working conditions that do not pose a risk of serious harm. • Receive information and training (in a language and vocabulary the worker understands) about workplace hazards, methods to prevent them, and the OSHA standards that apply to that workplace. • Review records of work-related injuries and illnesses. • File a complaint asking OSHA to inspect their workplace if they believe there is a serious..>> view originalCouple plays waiting game with Alzheimer's
CROWN POINT, Ind. (AP) — “I don’t think there’s a day I get up that I don’t think about something going wrong.”As John Unterfranz said this, with sunlight bouncing off a nearby lake and illuminating the inside of his home, he wore a look of frustration, of worry, of resignation. But he also had reason to keep fighting. Several reasons.“The thing that keeps me going is her,” the 63-year-old said, motioning toward his wife, Jeanne, seated next to him at their kitchen table. “Also, my four kids. A..>> view originalSex May Spread Zika Virus More Often Than Researchers Suspected
If sexual transmission is more common than believed, efforts to protect women may draw health officials in many of these countries into conflict with those who oppose greater access to birth control or more explicit discussion of sexual practices.In most parts of the United States, including New York City, health officials have presumed that the risk of Zika infection is low, except possibly at the peak of summer, the height of the mosquito season.But wider sexual transmission may alter that ca..>> view originalMarijuana agent removes brain-damaging effects of Alzheimer
A new study suggests that marijuana compounds may remove toxic brain proteins associated with Alzheimer’s disease. Researchers from Salk Institute in California lab-grown tests to assess the effect of cannabis properties when clearing up brain plaque. A new study, published in the journal Aging and Mechanisms of Disease, showed that compounds in marijuana could remove brain damage effects as well as neurological inflammation linked to Alzheimer disease. To achieve this purpose, researchers car..>> view original
Monday, July 4, 2016
The Big Loser After Gilead's Latest Approval May Not Be Who You Think (Hint: It's not AbbVie, Inc.) and other top stories.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment